Peroxisome proliferator-activated receptor gamma and atherosclerosis (Q34492831)

2 August 2017

1 reference

title

Peroxisome proliferator-activated receptor gamma and atherosclerosis (English)

1 reference

2 August 2017

1 reference

Nikolaus Marx

1

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Current Hypertension Reports

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

71-77

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-002-0056-8

2 August 2017

exact match

0 references

cites work

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0056-8

21 January 2018

1 reference

12 December 2020

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

12 December 2020

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

1 reference

12 December 2020

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

1 reference

12 December 2020

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

12 December 2020

Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells

1 reference

12 December 2020

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

12 December 2020

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

1 reference

12 December 2020

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

12 December 2020

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

12 December 2020

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

12 December 2020

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

12 December 2020

Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques

1 reference

12 December 2020

Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients.

1 reference

12 December 2020

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

12 December 2020

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

12 December 2020

Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

12 December 2020

Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus.

1 reference

12 December 2020

Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response

1 reference

12 December 2020

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

12 December 2020

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1 reference

12 December 2020

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

12 December 2020

Transcriptional control of adipogenesis

1 reference

12 December 2020

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

1 reference

12 December 2020

Macrophages and atherosclerotic plaque stability.

1 reference

12 December 2020

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

12 December 2020

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

12 December 2020

PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells

1 reference

12 December 2020

Angiogenic activity of the atherosclerotic carotid artery plaque

1 reference

12 December 2020

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study

1 reference

12 December 2020

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

12 December 2020

Troglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes

1 reference

12 December 2020

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

12 December 2020

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

12 December 2020

Peroxisome proliferator-activated receptors, orphans with ligands and functions

1 reference

12 December 2020

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

1 reference

12 December 2020

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

12 December 2020

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

12 December 2020

Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis

1 reference

12 December 2020

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

12 December 2020

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

12 December 2020

10.1007/S11906-002-0056-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1027228569

0 references

1 reference